M200
This is an old revision of this page, as edited by Aschlafly (talk | contribs) at 13:04, October 22, 2007. It may differ significantly from current revision.
M200 is a monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors.
M200 is also called volociximab.